Regenerex Pharma (RGPX) Cash & Equivalents (2010 - 2025)
Regenerex Pharma (RGPX) reported Cash & Equivalents of $11659.0 for Q3 2025, up 3865.65% year-over-year from $294.0 in Q3 2024, and down 93.24% on a QoQ basis from $172430.0 in Q2 2025.
Regenerex Pharma (RGPX) has 14 years of Cash & Equivalents data on file, last reported at $11659.0 in Q3 2025.
- Quarterly Cash & Equivalents rose 3865.65% year-over-year to $11659.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $11659.0 (up 3865.65% YoY) and the FY2025 annual result came in at $653025.0, up 175444.35% from the prior year.
- Cash & Equivalents fell to $11659.0 in Q3 2025 per RGPX's latest filing, from $172430.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $653025.0 in Q1 2025 and bottomed at $294.0 in Q3 2024.
- The 5-year median for Cash & Equivalents is $2714.5 (2021), against an average of $52515.4.
- The widest annual swing landed in 2024, when Cash & Equivalents tumbled 95.7%; it then soared 175444.35% in 2025.
- Tracing RGPX's Cash & Equivalents over 5 years: stood at $2789.0 in 2021, then plunged by 56.87% to $1203.0 in 2022, then soared by 553.03% to $7856.0 in 2023, then plunged by 95.7% to $338.0 in 2024, then surged by 3349.41% to $11659.0 in 2025.
- Per Business Quant, the three latest RGPX Cash & Equivalents figures stand at $11659.0 (Q3 2025), $172430.0 (Q2 2025), and $653025.0 (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11,659.00 |
| Jun 30, 2025 | 172,430.00 |
| Mar 31, 2025 | 653,025.00 |
| Dec 31, 2024 | 338.00 |
| Sep 30, 2024 | 294.00 |
| Mar 31, 2024 | 372.00 |
| Dec 31, 2023 | 7,856.00 |
| Sep 30, 2023 | 6,080.00 |
| Jun 30, 2023 | 67,754.00 |
| Mar 31, 2023 | 1,135.00 |
| Dec 31, 2022 | 1,203.00 |
| Sep 30, 2022 | 629.00 |
| Jun 30, 2022 | 1,672.00 |
| Mar 31, 2022 | 2,640.00 |
| Dec 31, 2021 | 2,789.00 |
| Sep 30, 2021 | 2,545.00 |
| Jun 30, 2021 | 5,954.00 |
| Mar 21, 2021 | 6,902.00 |
| Dec 31, 2020 | 1,721.00 |
| Sep 30, 2020 | 4,088.00 |
| Jun 30, 2020 | 3,316.00 |
| Mar 31, 2020 | 5,460.00 |
| Dec 31, 2019 | 3,137.00 |
| Sep 30, 2019 | 1,053.00 |
| Jun 30, 2019 | 138,098.00 |
| Mar 31, 2019 | 88,546.00 |
| Dec 31, 2018 | 32,079.00 |
| Sep 30, 2018 | 1,083.00 |
| Jun 30, 2018 | 1,130.00 |
| Mar 31, 2018 | 1,728.00 |
| Dec 31, 2017 | 3,767.00 |
| Sep 30, 2017 | 3,306.00 |
| Aug 31, 2014 | 11,560.00 |
| May 31, 2014 | 1,683.00 |
| Feb 28, 2014 | 868.00 |
| Nov 30, 2013 | 157.00 |
| Aug 31, 2013 | 5,271.00 |
| May 31, 2013 | 369.00 |
| Feb 28, 2013 | 4,780.00 |
| Nov 30, 2012 | 7,780.00 |
| Aug 31, 2012 | 4,186.00 |
| May 31, 2012 | 2,439.00 |
| Feb 29, 2012 | 6,444.00 |
| Nov 30, 2011 | 1,656.00 |
| Aug 31, 2011 | 698.00 |
| Nov 30, 2010 | 6,090.00 |